Literature DB >> 32053378

Liquid Degradable Poly(trimethylene-carbonate-co-5-hydroxy-trimethylene carbonate): An Injectable Drug Delivery Vehicle for Acid-Sensitive Drugs.

Sara Mohajeri1,2, Fei Chen1,2,3, Mitchell de Prinse1,2, Ta Phung1,2, Jonah Burke-Kleinman4, Donald H Maurice4, Brian G Amsden1,2.   

Abstract

Liquid, injectable hydrophobic polymers have advantages as degradable drug delivery vehicles; however, polymers examined for this purpose to date form acidic degradation products that may damage acid-sensitive drugs. Herein, we report on a new viscous liquid vehicle, poly(trimethylene carbonate-co-5-hydroxy-trimethylene carbonate), which degrades through intramolecular cyclization producing glycerol, carbon dioxide, and water-soluble trimethylene carbonate. Copolymer degradation durations from weeks to months were achieved with the 5-hydroxy-trimethylene carbonate (HTMC) content of the oligomer having the greatest impact on the degradation rate, with oligomers possessing a higher HTMC content degrading fastest. The degradation products were non-cytotoxic towards 3T3 fibroblasts and RAW 264.7 macrophages. These copolymers can be injected manually through standard gauge needles and, importantly, during in vitro degradation, the microenvironmental pH within the oligomers remained near neutral. Complete and sustained release of the acid-sensitive protein vascular endothelial growth factor was achieved, with the protein remaining highly bioactive throughout the release period. These copolymers represent a promising formulation for local and sustained release of acid sensitive drugs.

Entities:  

Keywords:  aliphatic polycarbonate; biodegradable polymer; microenvironmental pH; protein delivery

Mesh:

Substances:

Year:  2020        PMID: 32053378     DOI: 10.1021/acs.molpharmaceut.0c00064

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

1.  Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables.

Authors:  Marie-Emérentienne Cagnon; Silvio Curia; Juliette Serindoux; Jean-Manuel Cros; Feifei Ng; Adolfo Lopez-Noriega
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

2.  Efficacy Evaluation of Ciprofloxacin-Loaded Poly (Trimethylene Carbonate) Implants in the Treatment of Chronic Osteomyelitis.

Authors:  Yixiu Liu; A Liang; Xu Li; Zhihe Ma; Dan Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.